The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

The FDA cleared the first blood test on Friday to help diagnose Alzheimer's disease among older Americans already exhibiting signs and symptoms of the condition.

U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment ...

The Food and Drug Administration has cleared Fujirebio Diagnostics’ blood test to diagnose Alzheimer’s disease, the regulator ...

The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

In this environment, diagnostics and testing appear comparatively safer, and companies like GeneDx and Natera, Inc. (NTRA), another Prudent Healthcare model portfolio holding, appear to be better ...

US & Canada, April 28, 2025 (GLOBE NEWSWIRE) -- As per a new, comprehensive report from The Insight Partners, the Point of Care Diagnostics Market is experiencing significant growth owing to ...